129 related articles for article (PubMed ID: 29120811)
1. Magnetic resonance (MR) features in triple negative breast cancer (TNBC) vs receptor positive cancer (nTNBC).
Angelini G; Marini C; Iacconi C; Mazzotta D; Moretti M; Picano E; Morganti R
Clin Imaging; 2018; 49():12-16. PubMed ID: 29120811
[TBL] [Abstract][Full Text] [Related]
2. Morphological and Semiquantitative Kinetic Analysis on Dynamic Contrast Enhanced MRI in Triple Negative Breast Cancer Patients.
Gigli S; Amabile MI; David E; De Luca A; Grippo C; Manganaro L; Monti M; Ballesio L
Acad Radiol; 2019 May; 26(5):620-625. PubMed ID: 30145205
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of biological behavior between triple-negative breast cancer and non-triple- negative breast cancer].
Ma JG; Wang NJ; Yu WJ
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Oct; 31(10):1729-32. PubMed ID: 22027778
[TBL] [Abstract][Full Text] [Related]
4. Triple-negative breast cancer: correlation between MR imaging and pathologic findings.
Uematsu T; Kasami M; Yuen S
Radiology; 2009 Mar; 250(3):638-47. PubMed ID: 19244039
[TBL] [Abstract][Full Text] [Related]
5. MR imaging of triple-negative breast cancer.
Uematsu T
Breast Cancer; 2011 Jul; 18(3):161-4. PubMed ID: 21181317
[TBL] [Abstract][Full Text] [Related]
6. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
[TBL] [Abstract][Full Text] [Related]
7. Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes.
Youk JH; Son EJ; Chung J; Kim JA; Kim EK
Eur Radiol; 2012 Aug; 22(8):1724-34. PubMed ID: 22527371
[TBL] [Abstract][Full Text] [Related]
8. [Breast cancer subtypes based on ER/PR and Her2 expression: comparison of MR imaging features].
Hao L; Yu RS; Cui F; Ren XC; Xu HB; Xu KY
Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(11):819-23. PubMed ID: 23859386
[TBL] [Abstract][Full Text] [Related]
9. The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion.
Bogan D; Meile L; El Bastawisy A; Yousef HF; Zekri AN; Bahnassy AA; ElShamy WM
BMC Cancer; 2017 May; 17(1):329. PubMed ID: 28499366
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathologic features and prognosis of triple negative breast cancer].
Zhou T; Yang L; Ma GM; Li CX; Bai Y; Zhao JA; Wang XL; Geng CZ
Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(32):2261-4. PubMed ID: 20095338
[TBL] [Abstract][Full Text] [Related]
11. Quantification of breast tumor heterogeneity for ER status, HER2 status, and TN molecular subtype evaluation on DCE-MRI.
Chang RF; Chen HH; Chang YC; Huang CS; Chen JH; Lo CM
Magn Reson Imaging; 2016 Jul; 34(6):809-819. PubMed ID: 26968141
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging of breast cancer and correlation with prognostic factors.
Chang YW; Kwon KH; Choi DL; Lee DW; Lee MH; Lee HK; Yang SB; Kim Y; Seo DY
Acta Radiol; 2009 Nov; 50(9):990-8. PubMed ID: 19863408
[TBL] [Abstract][Full Text] [Related]
13. Triple-negative breast cancer survival in Iranian patients.
Aghili M; Lashkari M; Farrokhpey AH; Izadi S
Acta Med Iran; 2013 Sep; 51(8):560-6. PubMed ID: 24026994
[TBL] [Abstract][Full Text] [Related]
14. The relationship of breast density in mammography and magnetic resonance imaging in women with triple negative breast cancer.
Mema E; Schnabel F; Chun J; Kaplowitz E; Price A; Goodgal J; Moy L
Eur J Radiol; 2020 Mar; 124():108813. PubMed ID: 31927471
[TBL] [Abstract][Full Text] [Related]
15. Is breast conservation therapy a viable option for patients with triple-receptor negative breast cancer?
Parker CC; Ampil F; Burton G; Li BD; Chu QD
Surgery; 2010 Aug; 148(2):386-91. PubMed ID: 20580045
[TBL] [Abstract][Full Text] [Related]
16. Novel prognostic markers for patients with triple-negative breast cancer.
Zhou L; Li K; Luo Y; Tian L; Wang M; Li C; Huang Q
Hum Pathol; 2013 Oct; 44(10):2180-7. PubMed ID: 23845466
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological comparison of triple negative breast cancers with non-triple negative breast cancers in a hospital in North India.
Nabi MG; Ahangar A; Wahid MA; Kuchay S
Niger J Clin Pract; 2015; 18(3):381-6. PubMed ID: 25772923
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of Triple-Negative Breast Cancers (TNBC) Compared with Non-TNBC: Does the Survival Vary for All Stages?
Agarwal G; Nanda G; Lal P; Mishra A; Agarwal A; Agrawal V; Krishnani N
World J Surg; 2016 Jun; 40(6):1362-72. PubMed ID: 26842691
[TBL] [Abstract][Full Text] [Related]
19. Is there a correlation between 3T multiparametric MRI and molecular subtypes of breast cancer?
Montemezzi S; Camera L; Giri MG; Pozzetto A; Caliò A; Meliadò G; Caumo F; Cavedon C
Eur J Radiol; 2018 Nov; 108():120-127. PubMed ID: 30396643
[TBL] [Abstract][Full Text] [Related]
20. Triple-negative breast cancer: the impact of guideline-adherent adjuvant treatment on survival--a retrospective multi-centre cohort study.
Schwentner L; Wolters R; Koretz K; Wischnewsky MB; Kreienberg R; Rottscholl R; Wöckel A
Breast Cancer Res Treat; 2012 Apr; 132(3):1073-80. PubMed ID: 22205141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
